We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-6.45%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$440M
AUM Growth
+$68.3M
Cap. Flow
+$121M
Cap. Flow %
27.55%
Top 10 Hldgs %
7.16%
Holding
1,009
New
355
Increased
190
Reduced
143
Closed
321

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$7.33M
2
AZN icon
AstraZeneca
AZN
+$3.83M
3
SPB icon
Spectrum Brands
SPB
+$3.54M
4
BNS icon
Scotiabank
BNS
+$3.5M
5
TSN icon
Tyson Foods
TSN
+$3.37M

Top Sells

Rank Stock Value
1
VIRT icon
Virtu Financial
VIRT
+$3.48M
2
DOV icon
Dover
DOV
+$2.95M
3
TU icon
Telus
TU
+$2.82M
4
SYK icon
Stryker
SYK
+$2.58M
5
TTWO icon
Take-Two Interactive
TTWO
+$2.49M

Sector Composition

Rank Sector Weight
1 Healthcare 18.71%
2 Technology 17.25%
3 Industrials 13.57%
4 Financials 13.31%
5 Consumer Discretionary 12.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PII icon
301
Polaris
PII
$3.91B
$523K 0.12%
5,464
+1,060
+24% +$119K
ACA icon
302
Arcosa
ACA
$7.12B
$520K 0.12%
+9,098
New +$504K
EPR icon
303
EPR Properties
EPR
$4.73B
$519K 0.12%
14,480
-224
-2% -$10.6K
MRO
304
DELISTED
Marathon Oil Corporation
MRO
$518K 0.12%
22,951
-20,697
-47% -$490K
NTR icon
305
Nutrien
NTR
$32.2B
$515K 0.12%
6,175
-264
-4% -$22.7K
MTB icon
306
M&T Bank
MTB
$36.6B
$514K 0.12%
+2,913
New +$515K
ALNY icon
307
Alnylam Pharmaceuticals
ALNY
$30.4B
$512K 0.12%
2,558
-2,983
-54% -$569K
BZUN
308
Baozun
BZUN
$168M
$512K 0.12%
+81,569
New +$699K
PRTA icon
309
Prothena Corp
PRTA
$466M
$511K 0.12%
+8,423
New +$266K
SPWR
310
DELISTED
SunPower Corporation Common Stock
SPWR
$510K 0.12%
+22,155
New +$498K
MSBI icon
311
Midland States Bancorp
MSBI
$698M
$504K 0.11%
21,385
-1,168
-5% -$30.1K
ALT icon
312
Altimmune
ALT
$560M
$502K 0.11%
+39,317
New +$580K
THC icon
313
Tenet Healthcare
THC
$21.5B
$502K 0.11%
9,731
-5,379
-36% -$319K
CTBI icon
314
Community Trust Bancorp
CTBI
$1.44B
$501K 0.11%
12,362
+7,001
+131% +$297K
MCHB
315
Mechanics Bancorp
MCHB
$3.79B
$500K 0.11%
17,339
-85
-0.5% -$2.99K
IP icon
316
International Paper
IP
$21.8B
$500K 0.11%
+15,780
New +$645K
EXPO icon
317
Exponent
EXPO
$3.24B
$499K 0.11%
+5,687
New +$539K
ADBE icon
318
Adobe
ADBE
$108B
$498K 0.11%
+1,808
New +$684K
VCYT icon
319
Veracyte
VCYT
$3.42B
$498K 0.11%
+29,991
New +$675K
ESNT icon
320
Essent Group
ESNT
$6.23B
$497K 0.11%
+14,258
New +$571K
MLKN icon
321
MillerKnoll
MLKN
$1.62B
$497K 0.11%
31,878
+24,099
+310% +$662K
APPS icon
322
Digital Turbine
APPS
$1.53B
$494K 0.11%
34,290
+22,693
+196% +$434K
AKAM icon
323
Akamai
AKAM
$18B
$492K 0.11%
+6,120
New +$557K
PSX icon
324
Phillips 66
PSX
$92.8B
$492K 0.11%
6,097
-5,491
-47% -$468K
SNDR icon
325
Schneider National
SNDR
$6.37B
$489K 0.11%
24,074
-2,105
-8% -$48.9K
11 12
13
14 15

Similar funds

BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Campbell & Co Investment Adviser's Q3 2022 Portfolio in Review

As of Q3 2022, Campbell & Co Investment Adviser held 1,009 positions worth $440M, up 18% from $372M the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Campbell & Co Investment Adviser deployed $121M of net new capital in Q3 2022, opening 355 new positions and adding to 190 existing holdings. Its largest new stake was GSK: 193,518 shares worth $5.7M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Dover, an estimated $2.95M trimmed.

  • Campbell & Co Investment Adviser's largest Q3 2022 buy was GSK: 193,518 shares worth $5.7M.
  • Campbell & Co Investment Adviser added most to Scotiabank in Q3 2022, an estimated $3.5M increase.
  • Campbell & Co Investment Adviser's biggest Q3 2022 reduction was Dover, cutting an estimated $2.95M.
  • Campbell & Co Investment Adviser fully exited Virtu Financial in Q3 2022, selling an estimated $3.48M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 7.2% of its $440M portfolio in Q3 2022.
  • Campbell & Co Investment Adviser opened 355 new positions and closed 321 in Q3 2022.
  • Campbell & Co Investment Adviser's portfolio value rose 18% quarter-over-quarter to $440M.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2022, filed 14 Nov 2022.